25 XP   0   0   10

ChromoGenics AB
Buy, Hold or Sell?

Let's analyse Chromogenics together

PenkeI guess you are interested in ChromoGenics AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ChromoGenics AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ChromoGenics AB

I send you an email if I find something interesting about ChromoGenics AB.

Quick analysis of Chromogenics (30 sec.)










What can you expect buying and holding a share of Chromogenics? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr10.95
Expected worth in 1 year
kr20.85
How sure are you?
27.3%

+ What do you gain per year?

Total Gains per Share
kr9.90
Return On Investment
137.1%

For what price can you sell your share?

Current Price per Share
kr7.22
Expected price per share
kr6 - kr8
How sure are you?
50%

1. Valuation of Chromogenics (5 min.)




Live pricePrice per Share (EOD)

kr7.22

Intrinsic Value Per Share

kr-127.16 - kr-151.74

Total Value Per Share

kr-116.20 - kr-140.79

2. Growth of Chromogenics (5 min.)




Is Chromogenics growing?

Current yearPrevious yearGrowGrow %
How rich?$4.1m$6.4m-$1.4m-29.0%

How much money is Chromogenics making?

Current yearPrevious yearGrowGrow %
Making money-$1.2m-$1.3m$100.2k8.2%
Net Profit Margin-476.0%-364.4%--

How much money comes from the company's main activities?

3. Financial Health of Chromogenics (5 min.)




4. Comparing to competitors in the Building Products & Equipment industry (5 min.)




  Industry Rankings (Building Products & Equipment)  


Richest
#212 / 226

Most Revenue
#222 / 226

Most Profit
#187 / 226

Most Efficient
#223 / 226

What can you expect buying and holding a share of Chromogenics? (5 min.)

Welcome investor! Chromogenics's management wants to use your money to grow the business. In return you get a share of Chromogenics.

What can you expect buying and holding a share of Chromogenics?

First you should know what it really means to hold a share of Chromogenics. And how you can make/lose money.

Speculation

The Price per Share of Chromogenics is kr7.22. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chromogenics.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chromogenics, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr10.95. Based on the TTM, the Book Value Change Per Share is kr2.48 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chromogenics.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.37-5.1%-0.16-2.2%-0.03-0.4%-0.25-3.4%-0.28-3.9%
Usd Book Value Change Per Share-0.31-4.3%0.233.1%-0.01-0.1%0.091.3%0.030.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.31-4.3%0.233.1%-0.01-0.1%0.091.3%0.030.4%
Usd Price Per Share0.64-0.31-0.06-0.17-0.11-
Price to Earnings Ratio-0.43--0.44--0.48--0.45--0.28-
Price-to-Total Gains Ratio-2.04--0.76--0.46--0.70--0.52-
Price to Book Ratio0.64-0.43-0.39-0.37-0.23-
Price-to-Total Gains Ratio-2.04--0.76--0.46--0.70--0.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.658464
Number of shares1518
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.230.09
Usd Total Gains Per Share0.230.09
Gains per Quarter (1518 shares)342.70142.78
Gains per Year (1518 shares)1,370.81571.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10137113610571561
2027422732011421132
3041124103017131703
4054835474022842274
5068546845028562845
6082258216034273416
7095969587039983987
801096610958045694558
901233712329051405129
1001370813700057115700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.033.00.00.0%0.033.00.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%7.013.00.035.0%9.022.02.027.3%9.022.02.027.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.033.00.0%0.00.033.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%7.013.00.035.0%9.022.02.027.3%9.022.02.027.3%

Fundamentals of Chromogenics

About ChromoGenics AB

ChromoGenics AB provides glass products in Sweden. It offers dynamic and static glasses, and colored solar facades under the ConverLight name. The company was incorporated in 2002 and is headquartered in Uppsala, Sweden.

Fundamental data was last updated by Penke on 2024-03-30 07:18:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of ChromoGenics AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Chromogenics earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Chromogenics to the Building Products & Equipment industry mean.
  • A Net Profit Margin of -665.8% means that kr-6.66 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ChromoGenics AB:

  • The MRQ is -665.8%. The company is making a huge loss. -2
  • The TTM is -476.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-665.8%TTM-476.0%-189.8%
TTM-476.0%YOY-364.4%-111.6%
TTM-476.0%5Y-424.1%-51.9%
5Y-424.1%10Y-667.9%+243.8%
Compared to industry (Building Products & Equipment)
PeriodCompanyIndustry (mean)+/- 
MRQ-665.8%4.1%-669.9%
TTM-476.0%4.3%-480.3%
YOY-364.4%5.8%-370.2%
5Y-424.1%4.9%-429.0%
10Y-667.9%4.9%-672.8%
1.1.2. Return on Assets

Shows how efficient Chromogenics is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chromogenics to the Building Products & Equipment industry mean.
  • -11.9% Return on Assets means that Chromogenics generated kr-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ChromoGenics AB:

  • The MRQ is -11.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.9%TTM-9.0%-2.9%
TTM-9.0%YOY-8.5%-0.6%
TTM-9.0%5Y-10.1%+1.1%
5Y-10.1%10Y-16.7%+6.5%
Compared to industry (Building Products & Equipment)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.9%1.6%-13.5%
TTM-9.0%1.7%-10.7%
YOY-8.5%2.2%-10.7%
5Y-10.1%2.1%-12.2%
10Y-16.7%2.1%-18.8%
1.1.3. Return on Equity

Shows how efficient Chromogenics is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chromogenics to the Building Products & Equipment industry mean.
  • -38.8% Return on Equity means Chromogenics generated kr-0.39 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ChromoGenics AB:

  • The MRQ is -38.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -25.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-38.8%TTM-25.7%-13.2%
TTM-25.7%YOY-20.4%-5.3%
TTM-25.7%5Y-35.4%+9.8%
5Y-35.4%10Y-38.4%+2.9%
Compared to industry (Building Products & Equipment)
PeriodCompanyIndustry (mean)+/- 
MRQ-38.8%3.3%-42.1%
TTM-25.7%3.6%-29.3%
YOY-20.4%4.6%-25.0%
5Y-35.4%4.2%-39.6%
10Y-38.4%5.0%-43.4%

1.2. Operating Efficiency of ChromoGenics AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Chromogenics is operating .

  • Measures how much profit Chromogenics makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chromogenics to the Building Products & Equipment industry mean.
  • An Operating Margin of -677.3% means the company generated kr-6.77  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ChromoGenics AB:

  • The MRQ is -677.3%. The company is operating very inefficient. -2
  • The TTM is -446.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-677.3%TTM-446.7%-230.6%
TTM-446.7%YOY-367.9%-78.8%
TTM-446.7%5Y-402.0%-44.7%
5Y-402.0%10Y-652.0%+250.0%
Compared to industry (Building Products & Equipment)
PeriodCompanyIndustry (mean)+/- 
MRQ-677.3%6.8%-684.1%
TTM-446.7%5.7%-452.4%
YOY-367.9%7.8%-375.7%
5Y-402.0%7.4%-409.4%
10Y-652.0%7.2%-659.2%
1.2.2. Operating Ratio

Measures how efficient Chromogenics is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Building Products & Equipment industry mean).
  • An Operation Ratio of 7.77 means that the operating costs are kr7.77 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of ChromoGenics AB:

  • The MRQ is 7.773. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.506. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ7.773TTM5.506+2.267
TTM5.506YOY4.682+0.824
TTM5.5065Y5.060+0.446
5Y5.06010Y7.510-2.450
Compared to industry (Building Products & Equipment)
PeriodCompanyIndustry (mean)+/- 
MRQ7.7731.356+6.417
TTM5.5061.276+4.230
YOY4.6821.052+3.630
5Y5.0601.205+3.855
10Y7.5101.115+6.395

1.3. Liquidity of ChromoGenics AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Chromogenics is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Building Products & Equipment industry mean).
  • A Current Ratio of 1.09 means the company has kr1.09 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of ChromoGenics AB:

  • The MRQ is 1.088. The company is just able to pay all its short-term debts.
  • The TTM is 1.383. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.088TTM1.383-0.295
TTM1.383YOY1.382+0.001
TTM1.3835Y1.719-0.336
5Y1.71910Y2.136-0.418
Compared to industry (Building Products & Equipment)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0881.666-0.578
TTM1.3831.685-0.302
YOY1.3821.691-0.309
5Y1.7191.660+0.059
10Y2.1361.580+0.556
1.3.2. Quick Ratio

Measures if Chromogenics is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chromogenics to the Building Products & Equipment industry mean.
  • A Quick Ratio of 0.72 means the company can pay off kr0.72 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ChromoGenics AB:

  • The MRQ is 0.716. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.947. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.716TTM0.947-0.232
TTM0.947YOY0.921+0.026
TTM0.9475Y1.270-0.322
5Y1.27010Y1.630-0.360
Compared to industry (Building Products & Equipment)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7160.727-0.011
TTM0.9470.806+0.141
YOY0.9210.782+0.139
5Y1.2700.876+0.394
10Y1.6300.851+0.779

1.4. Solvency of ChromoGenics AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Chromogenics assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chromogenics to Building Products & Equipment industry mean.
  • A Debt to Asset Ratio of 0.68 means that Chromogenics assets are financed with 67.5% credit (debt) and the remaining percentage (100% - 67.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ChromoGenics AB:

  • The MRQ is 0.675. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.634. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.675TTM0.634+0.041
TTM0.634YOY0.585+0.049
TTM0.6345Y0.607+0.027
5Y0.60710Y0.840-0.233
Compared to industry (Building Products & Equipment)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6750.487+0.188
TTM0.6340.487+0.147
YOY0.5850.492+0.093
5Y0.6070.516+0.091
10Y0.8400.505+0.335
1.4.2. Debt to Equity Ratio

Measures if Chromogenics is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chromogenics to the Building Products & Equipment industry mean.
  • A Debt to Equity ratio of 219.8% means that company has kr2.20 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ChromoGenics AB:

  • The MRQ is 2.198. The company is just not able to pay all its debts with equity.
  • The TTM is 1.782. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.198TTM1.782+0.416
TTM1.782YOY1.416+0.366
TTM1.7825Y2.009-0.227
5Y2.00910Y1.811+0.198
Compared to industry (Building Products & Equipment)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1980.946+1.252
TTM1.7820.948+0.834
YOY1.4160.968+0.448
5Y2.0091.122+0.887
10Y1.8111.090+0.721

2. Market Valuation of ChromoGenics AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Chromogenics generates.

  • Above 15 is considered overpriced but always compare Chromogenics to the Building Products & Equipment industry mean.
  • A PE ratio of -0.43 means the investor is paying kr-0.43 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ChromoGenics AB:

  • The EOD is -0.449. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.435. Based on the earnings, the company is expensive. -2
  • The TTM is -0.442. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.449MRQ-0.435-0.014
MRQ-0.435TTM-0.442+0.007
TTM-0.442YOY-0.482+0.040
TTM-0.4425Y-0.452+0.010
5Y-0.45210Y-0.283-0.169
Compared to industry (Building Products & Equipment)
PeriodCompanyIndustry (mean)+/- 
EOD-0.44913.965-14.414
MRQ-0.43513.178-13.613
TTM-0.44211.786-12.228
YOY-0.48213.496-13.978
5Y-0.45216.016-16.468
10Y-0.28317.499-17.782
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ChromoGenics AB:

  • The EOD is -0.646. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.626. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.923. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.646MRQ-0.626-0.020
MRQ-0.626TTM-0.923+0.297
TTM-0.923YOY5.115-6.039
TTM-0.9235Y0.551-1.474
5Y0.55110Y0.325+0.226
Compared to industry (Building Products & Equipment)
PeriodCompanyIndustry (mean)+/- 
EOD-0.6465.248-5.894
MRQ-0.6265.240-5.866
TTM-0.9235.431-6.354
YOY5.1154.250+0.865
5Y0.5513.092-2.541
10Y0.3254.505-4.180
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Chromogenics is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Building Products & Equipment industry mean).
  • A PB ratio of 0.64 means the investor is paying kr0.64 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of ChromoGenics AB:

  • The EOD is 0.659. Based on the equity, the company is cheap. +2
  • The MRQ is 0.639. Based on the equity, the company is cheap. +2
  • The TTM is 0.430. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.659MRQ0.639+0.020
MRQ0.639TTM0.430+0.209
TTM0.430YOY0.392+0.038
TTM0.4305Y0.367+0.063
5Y0.36710Y0.233+0.134
Compared to industry (Building Products & Equipment)
PeriodCompanyIndustry (mean)+/- 
EOD0.6591.701-1.042
MRQ0.6391.953-1.314
TTM0.4301.898-1.468
YOY0.3921.981-1.589
5Y0.3671.978-1.611
10Y0.2332.006-1.773
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ChromoGenics AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---3.4332.475-239%-0.092-97%1.031-433%0.332-1134%
Book Value Per Share--10.9536.533+68%1.493+633%7.271+51%4.245+158%
Current Ratio--1.0881.383-21%1.382-21%1.719-37%2.136-49%
Debt To Asset Ratio--0.6750.634+6%0.585+15%0.607+11%0.840-20%
Debt To Equity Ratio--2.1981.782+23%1.416+55%2.009+9%1.811+21%
Dividend Per Share----0%-0%-0%-0%
Eps---4.024-1.713-57%-0.305-92%-2.691-33%-3.050-24%
Free Cash Flow Per Share---2.796-0.913-67%-0.322-88%-2.642-6%-2.933+5%
Free Cash Flow To Equity Per Share---3.0080.083-3715%0.194-1652%0.536-662%0.281-1170%
Gross Profit Margin--1.0001.0000%1.0000%1.034-3%1.088-8%
Intrinsic Value_10Y_max---151.741--------
Intrinsic Value_10Y_min---127.157--------
Intrinsic Value_1Y_max---5.070--------
Intrinsic Value_1Y_min---4.974--------
Intrinsic Value_3Y_max---22.959--------
Intrinsic Value_3Y_min---21.762--------
Intrinsic Value_5Y_max---50.159--------
Intrinsic Value_5Y_min---45.892--------
Market Cap29782283.400+3%28874790.00023011832.868+25%28635510.456+1%24298937.878+19%15229437.860+90%
Net Profit Margin---6.658-4.760-29%-3.644-45%-4.241-36%-6.679+0%
Operating Margin---6.773-4.467-34%-3.679-46%-4.020-41%-6.520-4%
Operating Ratio--7.7735.506+41%4.682+66%5.060+54%7.510+4%
Pb Ratio0.659+3%0.6390.430+49%0.392+63%0.367+74%0.233+175%
Pe Ratio-0.449-3%-0.435-0.442+2%-0.482+11%-0.452+4%-0.283-35%
Price Per Share7.220+3%7.0003.394+106%0.636+1000%1.876+273%1.259+456%
Price To Free Cash Flow Ratio-0.646-3%-0.626-0.923+48%5.115-112%0.551-214%0.325-293%
Price To Total Gains Ratio-2.103-3%-2.039-0.762-63%-0.458-78%-0.696-66%-0.518-75%
Quick Ratio--0.7160.947-24%0.921-22%1.270-44%1.630-56%
Return On Assets---0.119-0.090-24%-0.085-29%-0.101-15%-0.167+40%
Return On Equity---0.388-0.257-34%-0.204-47%-0.354-9%-0.384-1%
Total Gains Per Share---3.4332.475-239%-0.092-97%1.031-433%0.332-1134%
Usd Book Value--4120416.0004984992.000-17%6432609.600-36%6039464.640-32%3599575.564+14%
Usd Book Value Change Per Share---0.3130.226-239%-0.008-97%0.094-433%0.030-1134%
Usd Book Value Per Share--0.9990.596+68%0.136+633%0.663+51%0.387+158%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.367-0.156-57%-0.028-92%-0.245-33%-0.278-24%
Usd Free Cash Flow---1051809.600-971302.800-8%-1260703.200+20%-1703529.360+62%-1533489.309+46%
Usd Free Cash Flow Per Share---0.255-0.083-67%-0.029-88%-0.241-6%-0.267+5%
Usd Free Cash Flow To Equity Per Share---0.2740.008-3715%0.018-1652%0.049-662%0.026-1170%
Usd Market Cap2716144.246+3%2633380.8482098679.158+25%2611558.554+1%2216063.134+19%1388924.733+90%
Usd Price Per Share0.658+3%0.6380.310+106%0.058+1000%0.171+273%0.115+456%
Usd Profit---1513828.800-1217178.000-20%-1317429.600-13%-1441452.480-5%-1407406.691-7%
Usd Revenue--227361.600311106.000-27%416328.000-45%531048.480-57%380270.836-40%
Usd Total Gains Per Share---0.3130.226-239%-0.008-97%0.094-433%0.030-1134%
 EOD+5 -3MRQTTM+5 -28YOY+7 -265Y+7 -2710Y+14 -20

3.2. Fundamental Score

Let's check the fundamental score of ChromoGenics AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.449
Price to Book Ratio (EOD)Between0-10.659
Net Profit Margin (MRQ)Greater than0-6.658
Operating Margin (MRQ)Greater than0-6.773
Quick Ratio (MRQ)Greater than10.716
Current Ratio (MRQ)Greater than11.088
Debt to Asset Ratio (MRQ)Less than10.675
Debt to Equity Ratio (MRQ)Less than12.198
Return on Equity (MRQ)Greater than0.15-0.388
Return on Assets (MRQ)Greater than0.05-0.119
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of ChromoGenics AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.742
Ma 20Greater thanMa 506.830
Ma 50Greater thanMa 1006.975
Ma 100Greater thanMa 2006.932
OpenGreater thanClose7.020
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  2,368-3132,0551,2703,325-1,9861,339-18,223-16,884



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets139,163
Total Liabilities93,983
Total Stockholder Equity42,755
 As reported
Total Liabilities 93,983
Total Stockholder Equity+ 42,755
Total Assets = 139,163

Assets

Total Assets139,163
Total Current Assets29,758
Long-term Assets109,405
Total Current Assets
Cash And Cash Equivalents 7,926
Net Receivables 11,658
Inventory 10,174
Total Current Assets  (as reported)29,758
Total Current Assets  (calculated)29,758
+/-0
Long-term Assets
Property Plant Equipment 98,301
Long-term Assets Other 10,672
Long-term Assets  (as reported)109,405
Long-term Assets  (calculated)108,973
+/- 432

Liabilities & Shareholders' Equity

Total Current Liabilities27,362
Long-term Liabilities66,621
Total Stockholder Equity42,755
Total Current Liabilities
Short-term Debt 199
Accounts payable 2,770
Other Current Liabilities 24,393
Total Current Liabilities  (as reported)27,362
Total Current Liabilities  (calculated)27,362
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)66,621
Long-term Liabilities  (calculated)0
+/- 66,621
Total Stockholder Equity
Common Stock35,062
Retained Earnings -715,419
Accumulated Other Comprehensive Income 9,901
Other Stockholders Equity 713,211
Total Stockholder Equity (as reported)42,755
Total Stockholder Equity (calculated)42,755
+/-0
Other
Cash and Short Term Investments 7,926
Common Stock Shares Outstanding 4,121
Liabilities and Stockholders Equity 139,163
Net Debt 58,894
Net Working Capital 2,396
Short Long Term Debt Total 66,820



Balance Sheet

All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
> Total Assets 
45,023
0
0
30,640
34,717
119,603
100,414
84,767
71,410
79,560
65,237
53,121
46,662
86,400
194,299
155,815
132,054
175,919
156,905
139,914
213,833
203,468
186,888
179,685
160,444
196,336
171,868
148,302
161,501
154,066
143,604
158,728
139,163
139,163158,728143,604154,066161,501148,302171,868196,336160,444179,685186,888203,468213,833139,914156,905175,919132,054155,815194,29986,40046,66253,12165,23779,56071,41084,767100,414119,60334,71730,6400045,023
   > Total Current Assets 
14,451
0
0
4,327
10,965
97,292
79,352
65,206
52,524
59,944
45,543
30,006
25,503
67,074
120,553
80,340
50,010
88,012
60,007
40,627
111,378
97,457
76,818
66,439
45,685
80,543
53,577
31,324
46,049
39,328
29,561
45,348
29,758
29,75845,34829,56139,32846,04931,32453,57780,54345,68566,43976,81897,457111,37840,62760,00788,01250,01080,340120,55367,07425,50330,00645,54359,94452,52465,20679,35297,29210,9654,3270014,451
       Cash And Cash Equivalents 
10,915
0
0
2,112
8,516
82,514
66,961
56,701
38,462
48,269
29,423
12,484
7,521
43,024
14,850
48,223
24,850
61,227
36,120
21,302
93,390
69,182
48,495
28,214
18,851
49,393
22,895
8,547
24,126
16,659
5,651
20,320
7,926
7,92620,3205,65116,65924,1268,54722,89549,39318,85128,21448,49569,18293,39021,30236,12061,22724,85048,22314,85043,0247,52112,48429,42348,26938,46256,70166,96182,5148,5162,1120010,915
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,314
16,060
15,425
12,273
8,655
21,221
20,706
24,903
8,857
9,893
6,891
7,944
11,715
12,030
11,895
12,883
11,658
11,65812,88311,89512,03011,7157,9446,8919,8938,85724,90320,70621,2218,65512,27315,42516,0607,3140000000000000000
       Inventory 
1,146
0
0
176
0
282
3,910
1,592
6,124
5,233
9,831
10,145
7,420
7,017
9,409
7,498
6,749
10,725
8,462
7,052
8,245
7,054
7,617
13,322
11,011
13,831
17,398
8,228
10,198
10,639
12,015
12,144
10,174
10,17412,14412,01510,63910,1988,22817,39813,83111,01113,3227,6177,0548,2457,0528,46210,7256,7497,4989,4097,0177,42010,1459,8315,2336,1241,5923,9102820176001,146
       Other Current Assets 
2,390
0
0
2,039
2,449
14,496
8,481
6,913
7,938
6,442
6,289
7,377
10,562
17,033
96,294
24,619
18,411
16,060
15,425
12,273
9,743
21,221
20,706
24,903
15,823
17,319
13,284
1
64
7,112
8,350
1
0
018,3507,11264113,28417,31915,82324,90320,70621,2219,74312,27315,42516,06018,41124,61996,29417,03310,5627,3776,2896,4427,9386,9138,48114,4962,4492,039002,390
   > Long-term Assets 
30,572
0
0
26,313
23,752
22,311
21,062
19,561
18,886
19,616
19,694
23,115
21,159
19,326
73,746
75,475
82,044
87,907
96,898
99,287
102,455
106,011
110,070
113,246
114,759
115,793
118,291
116,978
115,452
114,738
114,043
113,380
109,405
109,405113,380114,043114,738115,452116,978118,291115,793114,759113,246110,070106,011102,45599,28796,89887,90782,04475,47573,74619,32621,15923,11519,69419,61618,88619,56121,06222,31123,75226,3130030,572
       Property Plant Equipment 
13,746
0
0
11,481
21,306
9,981
9,209
8,446
8,825
10,263
11,036
10,451
9,476
8,529
63,920
66,765
74,341
80,925
85,512
88,337
90,839
93,359
96,364
100,621
101,794
102,356
103,379
103,260
102,986
102,259
101,738
101,091
98,301
98,301101,091101,738102,259102,986103,260103,379102,356101,794100,62196,36493,35990,83988,33785,51280,92574,34166,76563,9208,5299,47610,45111,03610,2638,8258,4469,2099,98121,30611,4810013,746
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
4,211
0
0
0
3,308
0
0
0
2,406
0
0
0
1,483
0
0
0
645
0
0
0
0
00006450001,4830002,4060003,3080004,211000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
10,061
0
0
0
7,471
0
0
0
4,395
6,982
6,411
5,975
4,445
8,256
9,358
10,182
9,030
10,958
12,846
11,605
11,694
12,051
11,875
0
0
0011,87512,05111,69411,60512,84610,9589,03010,1829,3588,2564,4455,9756,4116,9824,3950007,47100010,06100000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,898
0
4,348
2,443
8,479
2,479
2,066
2,113
427
428
430
0
0
004304284272,1132,0662,4798,4792,4434,34805,89800000000000000000000
> Total Liabilities 
55,533
0
0
61,229
70,726
68,103
59,523
57,412
63,918
68,459
70,508
70,125
86,564
79,487
132,224
90,313
89,448
90,084
90,200
88,398
92,904
93,382
106,597
106,173
102,742
111,357
102,853
90,652
91,013
91,050
92,499
99,389
93,983
93,98399,38992,49991,05091,01390,652102,853111,357102,742106,173106,59793,38292,90488,39890,20090,08489,44890,313132,22479,48786,56470,12570,50868,45963,91857,41259,52368,10370,72661,2290055,533
   > Total Current Liabilities 
5,863
0
0
11,559
21,056
18,433
9,853
7,742
14,591
19,132
21,181
20,798
37,238
30,846
82,897
40,986
41,688
42,324
39,411
27,410
29,551
28,945
41,242
42,275
52,639
60,785
52,261
23,646
24,854
24,032
23,273
29,496
27,362
27,36229,49623,27324,03224,85423,64652,26160,78552,63942,27541,24228,94529,55127,41039,41142,32441,68840,98682,89730,84637,23820,79821,18119,13214,5917,7429,85318,43321,05611,559005,863
       Short-term Debt 
0
0
0
5,000
0
0
0
0
0
343
343
343
0
1,029
343
343
0
1,843
3,789
1,868
0
0
0
0
15,434
16,485
18,067
281
300
300
300
222
199
19922230030030028118,06716,48515,43400001,8683,7891,84303433431,0290343343343000005,000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,843
3,789
1,868
0
0
0
0
15,434
16,485
18,067
281
300
300
300
222
0
022230030030028118,06716,48515,43400001,8683,7891,84300000000000000000
       Accounts payable 
1,652
0
0
3,130
2,076
3,532
2,744
4,492
7,427
8,216
6,553
5,874
5,288
12,395
64,967
25,736
18,456
19,819
12,649
4,449
8,149
7,363
6,728
11,145
7,772
13,032
7,523
6,882
8,612
8,551
5,629
3,770
2,770
2,7703,7705,6298,5518,6126,8827,52313,0327,77211,1456,7287,3638,1494,44912,64919,81918,45625,73664,96712,3955,2885,8746,5538,2167,4274,4922,7443,5322,0763,130001,652
       Other Current Liabilities 
4,211
0
0
3,429
18,980
14,901
7,109
3,250
7,164
10,573
14,285
14,581
31,950
17,422
17,587
14,907
23,232
20,662
22,973
21,093
21,402
21,582
34,514
31,130
29,433
31,268
26,671
16,483
15,942
15,181
17,344
25,504
24,393
24,39325,50417,34415,18115,94216,48326,67131,26829,43331,13034,51421,58221,40221,09322,97320,66223,23214,90717,58717,42231,95014,58114,28510,5737,1643,2507,10914,90118,9803,429004,211
   > Long-term Liabilities 
49,670
0
0
49,670
49,670
49,670
49,670
49,670
49,327
49,327
49,327
49,327
49,326
48,641
49,327
49,327
47,760
47,760
50,789
60,988
63,353
64,437
65,355
63,898
50,103
50,572
50,592
67,006
66,159
67,018
69,226
69,893
66,621
66,62169,89369,22667,01866,15967,00650,59250,57250,10363,89865,35564,43763,35360,98850,78947,76047,76049,32749,32748,64149,32649,32749,32749,32749,32749,67049,67049,67049,67049,6700049,670
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
57,010
58,094
59,012
59,939
46,264
46,733
46,753
63,169
63,783
64,637
66,827
0
0
0066,82764,63763,78363,16946,75346,73346,26459,93959,01258,09457,01000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,975
4,975
6,343
6,343
6,343
3,959
3,839
3,839
3,839
3,838
2,376
2,381
2,399
0
0
002,3992,3812,3763,8383,8393,8393,8393,9596,3436,3436,3434,9754,975000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,133
0
0
0
6,027
0
0
0
0
0
0
0
0
000000006,0270001,13300000000000000000000
> Total Stockholder Equity
-10,510
0
0
-30,589
-36,009
51,500
40,891
27,355
7,492
11,101
-5,271
-17,004
-39,902
6,913
62,075
65,502
42,606
85,835
66,705
51,516
120,929
110,086
80,291
73,512
57,702
84,979
69,015
57,650
70,488
63,016
51,105
59,339
42,755
42,75559,33951,10563,01670,48857,65069,01584,97957,70273,51280,291110,086120,92951,51666,70585,83542,60665,50262,0756,913-39,902-17,004-5,27111,1017,49227,35540,89151,500-36,009-30,58900-10,510
   Common Stock
26,515
0
0
1,492
1,883
4,643
4,643
4,643
4,643
8,438
8,438
8,638
8,638
34,551
63,919
80,476
80,476
141,467
1,415
1,415
3,395
3,395
3,395
3,408
3,408
7,037
7,037
7,053
28,661
34,335
34,335
35,011
35,062
35,06235,01134,33534,33528,6617,0537,0377,0373,4083,4083,3953,3953,3951,4151,415141,46780,47680,47663,91934,5518,6388,6388,4388,4384,6434,6434,6434,6431,8831,4920026,515
   Retained Earnings -715,419-698,620-687,258-674,826-661,142-647,696-634,822-619,249-601,652-582,015-574,763-544,972-534,281-524,315-509,184-490,245-470,766-447,589-427,566-409,307-392,970-369,776-357,029-340,307-319,031-299,168-285,632-275,103-261,810-249,85000-237,559
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
432,158
433,875
573,736
573,678
650,036
649,884
649,880
650,340
650,330
691,575
691,185
691,169
694,939
694,783
694,730
0
0
00694,730694,783694,939691,169691,185691,575650,330650,340649,880649,884650,036573,678573,736433,875432,1580000000000000000
   Treasury Stock000000000000000000000000000000000
   Other Stockholders Equity 
200,534
0
0
217,769
223,918
321,960
321,880
321,880
321,880
342,970
343,320
344,134
344,430
381,669
425,722
432,615
432,896
434,613
574,474
574,416
651,815
651,663
651,659
652,119
655,946
697,191
696,800
698,293
694,839
694,783
694,730
713,247
713,211
713,211713,247694,730694,783694,839698,293696,800697,191655,946652,119651,659651,663651,815574,416574,474434,613432,896432,615425,722381,669344,430344,134343,320342,970321,880321,880321,880321,960223,918217,76900200,534



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue13,645
Cost of Revenue-64,279
Gross Profit-50,634-50,634
 
Operating Income (+$)
Gross Profit-50,634
Operating Expense-55,515
Operating Income-50,634-106,149
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense55,5150
 
Net Interest Income (+$)
Interest Income560
Interest Expense-4,311
Other Finance Cost-229
Net Interest Income-3,522
 
Pretax Income (+$)
Operating Income-50,634
Net Interest Income-3,522
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-52,509-48,759
EBIT - interestExpense = -54,945
-52,503
-48,195
Interest Expense4,311
Earnings Before Interest and Taxes (EBIT)-50,634-48,198
Earnings Before Interest and Taxes (EBITDA)-46,159
 
After tax Income (+$)
Income Before Tax-52,509
Tax Provision-4
Net Income From Continuing Ops-48,349-52,513
Net Income-52,506
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses64,279
Total Other Income/Expenses Net-1,8753,522
 

Technical Analysis of Chromogenics
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chromogenics. The general trend of Chromogenics is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chromogenics's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ChromoGenics AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.7 < 8 < 8.

The bearish price targets are: 6.08 > 6 > 6.

Tweet this
ChromoGenics AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ChromoGenics AB. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ChromoGenics AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ChromoGenics AB. The current macd is 0.08898363.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Chromogenics price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Chromogenics. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Chromogenics price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
ChromoGenics AB Daily Moving Average Convergence/Divergence (MACD) ChartChromoGenics AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ChromoGenics AB. The current adx is 18.21.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Chromogenics shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
ChromoGenics AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ChromoGenics AB. The current sar is 6.71241518.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
ChromoGenics AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ChromoGenics AB. The current rsi is 53.74. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
ChromoGenics AB Daily Relative Strength Index (RSI) ChartChromoGenics AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ChromoGenics AB. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Chromogenics price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
ChromoGenics AB Daily Stochastic Oscillator ChartChromoGenics AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ChromoGenics AB. The current cci is 50.93.

ChromoGenics AB Daily Commodity Channel Index (CCI) ChartChromoGenics AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ChromoGenics AB. The current cmo is 11.99.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
ChromoGenics AB Daily Chande Momentum Oscillator (CMO) ChartChromoGenics AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ChromoGenics AB. The current willr is -29.62962963.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Chromogenics is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
ChromoGenics AB Daily Williams %R ChartChromoGenics AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ChromoGenics AB.

ChromoGenics AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ChromoGenics AB. The current atr is 0.45272556.

ChromoGenics AB Daily Average True Range (ATR) ChartChromoGenics AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ChromoGenics AB. The current obv is -140,498.

ChromoGenics AB Daily On-Balance Volume (OBV) ChartChromoGenics AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ChromoGenics AB. The current mfi is 91.06.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
ChromoGenics AB Daily Money Flow Index (MFI) ChartChromoGenics AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ChromoGenics AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-02MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

ChromoGenics AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ChromoGenics AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.742
Ma 20Greater thanMa 506.830
Ma 50Greater thanMa 1006.975
Ma 100Greater thanMa 2006.932
OpenGreater thanClose7.020
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Chromogenics with someone you think should read this too:
  • Are you bullish or bearish on Chromogenics? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chromogenics? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ChromoGenics AB

I send you an email if I find something interesting about ChromoGenics AB.


Comments

How you think about this?

Leave a comment

Stay informed about ChromoGenics AB.

Receive notifications about ChromoGenics AB in your mailbox!